People who have lived with HIV long-term can need up to a dozen pills every day to suppress the virus. Results from a new ...

A single-pill treatment to suppress HIV proved as effective as existing therapies of up to 11 tablets daily, the latest advance in a scientific “golden age” for treating the virus even as rich ...

Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is ...

The state invoked emergency rule-making power for what advocates say will be another emergency, when HIV-positive patients lose medication assistance.

A phase 3 clinical trial, led by Professor Chloe Orkin of Queen Mary University of London, has shown that a new, daily oral tablet that combines two current HIV treatment medications – bictegravir and ...

Some African nations have teams that provide door-to-door health checkups, but HIV testing and drugs are often only available at clinics.

A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), may be able to effectively replace more complicated HIV treatment regimens used by ...

At the 2026 Conference on Retroviruses and Opportunistic Infections, Gilead and Merck demonstrated that their respective daily oral HIV drugs can match current therapies in keeping the virus at bay.

Kenya will roll out a groundbreaking new HIV-prevention drug in March across 15 priority regions, the health ministry said on Wednesday.

Ending funding for the Ryan White HIV/AIDS Program would result in an estimated 73% increase in HIV infections in 30 states over 5 years, according to a simulation study. An analysis of aggregated ...

Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the ...

Add Yahoo as a preferred source to see more of our stories on Google. Medications have kept Tori Samuel’s HIV at bay for decades. The part-time worker from Ocala, Florida, has thrived, marrying her ...